Prognostic Value of Molecular Breast Cancer Subtypes based on Her2, ESR1, PGR and Ki67 mRNA-Expression in Muscle Invasive Bladder Cancer.

CONCLUSION: Gene expression of Her2, ESR1, PGR, Ki67 and corresponding breast cancer subtypes allow a risk-stratification in MIBC, whereby Her2 overexpressing tumors reveal a particularly poor prognosis. PMID: 29477637 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29477637?dopt=Abstract

Source: Translational Oncology - February 22, 2018 Category: Cancer & Oncology Authors: Kriegmair MC, Wirtz RM, Worst TS, Breyer J, Ritter M, Keck B, Boehmer C, Otto W, Eckstein M, Weis CA, Hartmann A, Bolenz C, Erben P Tags: Transl Oncol Source Type: research